HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes.

Abstract
Fibromodulin (FMOD) was shown to be highly overexpressed in chronic lymphocytic leukemia (CLL) cells compared with normal B lymphocytes by gene expression profiling. Therefore FMOD might serve as potential tumor-associated antigen (TAA) in CLL, enabling expansion of FMOD-specific T cells. In CLL samples derived from 16 different patients, high expression of FMOD by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) was detectable in contrast to normal B lymphocytes. We used unpulsed native CLL cells and CD40 ligand (CD40L)-stimulated CLL cells as antigen-presenting cells (APCs) to expand autologous T cells from 13 patients. The number of T cells during 4 weeks of in vitro culture increased 2- to 3.5-fold and the number of T cells recognizing FMOD peptides bound to HLA-A2 dimers increased 10-fold. The expanded T cells also were able to secrete interferon-gamma (IFN-gamma) upon recognition of the antigen demonstrated by IFN-gamma ELISPOT assays. T cells not only recognized HLA-A2-binding FMOD peptides presented by transporter-associated with antigen-processing (TAP)-deficient T2 cells, but also FMOD overexpressing autologous CLL cells in an HLA-A2-restricted manner. In summary, FMOD was shown for the first time to be naturally processed and presented as TAA in primary CLL cells, enabling the expansion of autologous tumor-specific T cells.
AuthorsChristine Mayr, Dagmar Bund, Martin Schlee, Andreas Moosmann, David M Kofler, Michael Hallek, Clemens-Martin Wendtner
JournalBlood (Blood) Vol. 105 Issue 4 Pg. 1566-73 (Feb 15 2005) ISSN: 0006-4971 [Print] United States
PMID15471955 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • Epitopes, T-Lymphocyte
  • Extracellular Matrix Proteins
  • FMOD protein, human
  • HLA-A2 Antigen
  • Peptide Fragments
  • Proteoglycans
  • RNA, Messenger
  • Fibromodulin
  • CD40 Ligand
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigen Presentation
  • Antigen-Presenting Cells (immunology, metabolism, pathology)
  • Antigens, Neoplasm (biosynthesis, genetics, immunology, metabolism)
  • CD40 Ligand (pharmacology)
  • CD8-Positive T-Lymphocytes (immunology, metabolism, pathology)
  • Cell Line, Transformed
  • Cell Line, Tumor
  • Dimerization
  • Enzyme-Linked Immunosorbent Assay
  • Epitopes, T-Lymphocyte (immunology, metabolism)
  • Extracellular Matrix Proteins (biosynthesis, genetics, immunology, metabolism)
  • Female
  • Fibromodulin
  • HLA-A2 Antigen (immunology, metabolism)
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell (immunology, pathology)
  • Lymphocyte Activation (immunology)
  • Male
  • Middle Aged
  • Peptide Fragments (immunology, metabolism)
  • Proteoglycans (biosynthesis, genetics, immunology, metabolism)
  • RNA, Messenger (biosynthesis)
  • Staining and Labeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: